← Back to headlines
FDA approves Immuneering therapy for second-line metastatic pancreatic cancer
The biotech firm highlighted the regulatory milestone while reiterating its strategic focus on developing treatments for first-line patients in future trials.
26 Aug, 21:16 — 26 Aug, 21:16
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
1h ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
3h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago